Summary
The PRA Bioanalytical Laboratory has over 10 years of experience with transfer, development, validation, and bioanalysis of anti-drug antibody (ADA) assays in support of pre-clinical and clinical trials. Given the different types of biologics on the market and challenges of achieving appropriate sensitivity and drug tolerance for ADAs, PRA’s experienced scientists have the expertise to overcome and mitigate these challenges.
Register to download
Anti-drug antibody assays at PRA’s Laboratory for Drug Development
You may also be interested in:
Page
State-of-the-art Clinical Facilities
We provide end-to-end bioanalytical support from Pre-clinical to Phase IV studies. At PRA, our laboratories are managed, staffed, and supported by…
Resource
Biomarkers at PRA’s Laboratories for Drug Development
PRA understands that biomarker assays are not PK assays and that their Context of Use (CoU) must be defined prior to setting up a method. Since most…
Blog
PRA Lenexa Lab Celebrates Ten-Year Anniversary
Clinical trial development is experiencing a surge in scientific breakthroughs, thanks to the introduction of new technologies and services. As we…